Meropenem 500mg Pediatric IV Vial from Japan
Pediatric formulation vial with 500mg meropenem for weight-based dosing in children treating sepsis or complicated skin infections. Falls under HTS 3004.20.00.76 as a meropenem-containing antibiotic in measured doses for prophylactic and therapeutic uses in hospital settings. Dosage adjusted for safety in young patients.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Include pediatric-specific clinical trial data or approvals in documentation for age-appropriate importing
• Monitor for color change indicators on vials, as degradation affects classification and import viability
• Pair with import bonds for high-value pharmaceuticals to cover potential FDA holds